Baxter International, Inc. (BAX)

17.50 +0.52 (+3.09%) USD  |  NYSE  |  May 07, 16:00
17.43 -0.08 (-0.43%) Pre-Market: 20:00
More

Baxter International Research and Development Expense (Annual) : 503.00M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Becton, Dickinson & Co. 1.265B
ResMed, Inc. 331.28M
Abbott Laboratories 2.889B
Boston Scientific Corp. 2.052B
West Pharmaceutical Services, Inc. 74.30M